Inflectis Bioscience

Small Molecules to treat misfolding protein disorders such as Charcot-Marie-Tooth, Retinitis Pigmentosa

placeNantes, Pays De La Loire, France calendar_todayFounded 2013 groups8 employees language inflectisbioscience.com

Investor mix

3 investors on record; lead investors include Credit Mutuel Equity.

Investor typeCountShare
Venture capital133%
Private equity267%
Coming soon